These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 38261126)

  • 21. Risk-to-Benefit Relationship of Contralateral Prophylactic Mastectomy: The Argument for Bilateral Mastectomies with Immediate Reconstruction.
    Alba B; Schultz BD; Cohen D; Qin AL; Chan W; Tanna N
    Plast Reconstr Surg; 2019 Jul; 144(1):1-9. PubMed ID: 31246789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.
    Boughey JC; Attai DJ; Chen SL; Cody HS; Dietz JR; Feldman SM; Greenberg CC; Kass RB; Landercasper J; Lemaine V; MacNeill F; Song DH; Staley AC; Wilke LG; Willey SC; Yao KA; Margenthaler JA
    Ann Surg Oncol; 2016 Oct; 23(10):3100-5. PubMed ID: 27469117
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preserving choice in breast cancer treatment: A different perspective on contralateral prophylactic mastectomy.
    Pender K; Dodge D; Collins JM
    Womens Health (Lond); 2023; 19():17455057231175812. PubMed ID: 37218720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding Stakeholder Preference for Contralateral Prophylactic Mastectomy: A Conjoint Analysis.
    Shamsunder MG; Panchal H; Pilewskie M; Lee C; Razdan SN; Matros E
    J Am Coll Surg; 2021 Nov; 233(5):606-618.e1. PubMed ID: 34438077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mastectomy with Reconstruction Including Robotic Endoscopic Surgery (MARRES): a prospective cohort study of the Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG) and Korean Breast Cancer Study Group (KBCSG).
    Ryu JM; Lee J; Lee J; Ko B; Kim JH; Shin H; Park HS;
    BMC Cancer; 2023 Jun; 23(1):571. PubMed ID: 37344780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient preferences for locoregional therapy in early-stage breast cancer.
    Minami CA; King TA; Mittendorf EA
    Breast Cancer Res Treat; 2020 Sep; 183(2):291-309. PubMed ID: 32691377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
    King TA; Sakr R; Patil S; Gurevich I; Stempel M; Sampson M; Morrow M
    J Clin Oncol; 2011 Jun; 29(16):2158-64. PubMed ID: 21464413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction.
    Nealon KP; Sobti N; Gadd M; Specht M; Liao EC
    Breast Cancer Res Treat; 2020 Jan; 179(2):255-265. PubMed ID: 31605310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications for Contralateral Prophylactic Mastectomy: A Consensus Statement Using Modified Delphi Methodology.
    Wright FC; Look Hong NJ; Quan ML; Beyfuss K; Temple S; Covelli A; Baxter N; Gagliardi AR
    Ann Surg; 2018 Feb; 267(2):271-279. PubMed ID: 28594745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
    Lyman GH; Temin S; Edge SB; Newman LA; Turner RR; Weaver DL; Benson AB; Bosserman LD; Burstein HJ; Cody H; Hayman J; Perkins CL; Podoloff DA; Giuliano AE;
    J Clin Oncol; 2014 May; 32(13):1365-83. PubMed ID: 24663048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk-reducing mastectomy for the prevention of primary breast cancer.
    Carbine NE; Lostumbo L; Wallace J; Ko H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD002748. PubMed ID: 29620792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of the Breast Surgical Oncology Fellowship in the United States.
    Westcott LZ; Jones RC; Fleshman JW
    Breast J; 2022; 2022():3342910. PubMed ID: 35711884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When is contralateral mastectomy warranted in unilateral breast cancer?
    Barry M; Sacchini V
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1209-14. PubMed ID: 21916574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer.
    Baskin AS; Wang T; Bredbeck BC; Sinco BR; Berlin NL; Dossett LA
    J Surg Res; 2021 Jun; 262():71-84. PubMed ID: 33548676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
    Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
    Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innovation in Breast Surgery: Practical and Ethical Considerations.
    Teller P; Nguyen TT; Tseng J; Allen L; Matsen CB; Bellavance E; Kaufman D; Hieken T; Nagel S; Patten C; Pomerenke L; Tevis SE; Sarantou T
    Ann Surg Oncol; 2022 Oct; 29(10):6144-6150. PubMed ID: 35854028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plastic and Reconstructive Surgeons' Knowledge and Comfort of Contralateral Prophylactic Mastectomy: A Survey of the American Society of Plastic Surgeons.
    Lopez CD; Bluebond-Langner R; Houssock CA; Slezak SS; Bellavance E
    Front Oncol; 2018; 8():647. PubMed ID: 30687634
    [No Abstract]   [Full Text] [Related]  

  • 39. Breast Cancer Knowledge and Decisions Made for Contralateral Prophylactic Mastectomy: A Survey of Surgeons and Women in the General Population.
    Hooper RC; Hsu J; Duncan A; Bensenhaver JM; Newman LA; Kidwell KM; Chung KC; Momoh AO
    Plast Reconstr Surg; 2019 May; 143(5):936e-945e. PubMed ID: 31033815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
    Scheepens JCC; Veer LV'; Esserman L; Belkora J; Mukhtar RA
    Breast; 2021 Apr; 56():61-69. PubMed ID: 33621798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.